Buy or sell Berkeley Lights stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Berkeley Lights Stock
Cell Manipulation for Personalized Therapies
About Berkeley Lights Stock
Berkeley Lights, Inc. (BLI) is a platform for single cell manipulation that allows for researchers to analyze cells. It aims to provide platforms that automate the manipulation and analysis of cells. The Beacon platform, the company's flagship product, is suited for cell line development, antibody discovery, gene editing, and antibody engineering workflows. The platform uses optofluidics and light-based technology to automate the work of cloning, culturing and sorting specific cells from biological samples. By automating these processes, they aim to cut the time and human labor needed to develop cell lines, discover and engineer antibodies, and do gene editing.
On June 26, 2020, Berkeley Lights filed to go public. Click here to see Berkeley Light's IPO paperwork.
The company was founded in 2011 in Emeryville, California.
Investors
AJS Investments
Atinum Investment
Black Diamond Ventures
Cota Capital
Zymergen, Gusto, Berkeley Lights, Eight Sleep, OpenGov, Bonobos, Movandi, Bossa Nova Robotics, inDinero
KTB Network
Paxion Capital Partners
Innovium, H2O.ai, Berkeley Lights, Bossa Nova Robotics, Katerra
Sequoia Capital
Market Kurly, Robinhood, Airbnb, Instacart, Tokopedia, Stripe, DoorDash, Rappi, CoinSwitch Kuber, UiPath
Shangbay Capital
Varian
Walden Riverwood Ventures
Funding History
| August 2011 | $183K |
|---|---|
| April 2012 | $500K |
| August 2012 | $4.0M |
| July 2014 | $29.2M |
| April 2015 | $58.6M |
| November 2016 | $40.0M |
| June 2018 | $95.0M |
Management
Chief Executive Officer
Eric Hobbs
Chief Financial Officer
Shaun Holt
Chief Scientific Officer
Kevin Chapman, Ph.D.
Chief Technology Officer
Keith Breinlinger, Ph.D.
Vice President, People Operations
Sheri Kelleher
SVP, Marketing
John Proctor, Ph.D.
General Counsel
Stuart Merkadeau
SVP, Global Sales
Mark Lasinski
Press
nanalyze - Jul, 5 2020
GlobeNewswire - May, 12 2020
PR Newswire - Apr, 27 2020
San Francisco Business Times - Mar, 13 2020
PR Newswire - Mar, 9 2020
PR Newswire - Feb, 28 2020
PR Newswire - Jan, 2 2020
fiercebiotech - Oct, 1 2019
synbiobeta - Sep, 16 2019
finance - Sep, 5 2019
prnewswire - Aug, 7 2019
prnewswire - Jun, 10 2019
bioportfolio - May, 18 2019
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
